申请人:INOVACIA AB
公开号:WO2009150144A1
公开(公告)日:2009-12-17
The application relates to compounds of Formula (Ia): and pharmaceutically acceptable salts, solvates, hydrates, geometrical isomers, tautomers, optical isomersor N-oxides thereof. The application also relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the prophylaxis and treatment of medical conditions relating to disorders of the G-protein- coupled receptor GPR119, such as diabetes, obesity and osteoporosis.
该申请涉及到Formula (Ia)的化合物以及这些化合物的药用盐、溶剂合物、水合物、几何异构体、互变异构体、光学异构体或其N-氧化物。该申请还涉及包括这些化合物的药物组合物,以及利用这些化合物预防和治疗与G-蛋白偶联受体GPR119相关的医疗状况,如糖尿病、肥胖和骨质疏松症。